Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout
Janux Therapeutics' lead drug, JANX007, shows promising prostate cancer results with no serious side effects. Find out why ...
Urgent Solutions to Fight Cancer: How Helix BioPharma is Tackling the Toughest Challenges
Helix BioPharma is a clinical-stage biopharmaceutical company aiming to turn scientific breakthroughs into real-world solutions for some of the most difficult-to-treat cancers.
Lantern Pharma (NASDAQ:LTRN) Coverage Initiated by Analysts at Lake Street Capital
Lake Street Capital initiated coverage on shares of Lantern Pharma (NASDAQ:LTRN – Free Report) in a report released on Wednesday morning, Marketbeat Ratings reports. The firm issued a buy rating and a ...
HC Wainwright Issues Positive Estimate for BioAtla Earnings
Research analysts at HC Wainwright increased their Q1 2025 earnings per share (EPS) estimates for BioAtla in a report issued on Monday, March 31st. HC Wainwright analyst A. He now anticipates that the ...